
    
      PRIMARY OBJECTIVES:

      I. To identify, using next generation sequencing, rare variants of large effect size that
      impact the risk of peripheral neuropathy in patients of African and European descent in the
      clinical trial ECOG-5103 (E5103).

      OUTLINE:

      Previously collected germline DNA samples are analyzed via whole exome sequencing.
    
  